Translational Neurodegeneration (ISSN 2047-9158) is an open-access journal published by Springer Nature in the United Kingdom. It covers Medicine, Neuroscience, Cellular and Molecular Neuroscience and Cognitive Neuroscience. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 19.1, Scopus Q1, Web of Science Q1, CiteScore 25.9 and HEC W-Category. Article processing charge: USD 3,090.
Translational Neurodegeneration
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q1 journals · HEC W category journals · Scopus journals · Web of Science journals · PubMed journals · DOAJ journals · SCImago journals · SCIE journals · Open access journals
Quick answers about Translational Neurodegeneration
Is Translational Neurodegeneration HEC recognised?
Yes. The catalogue records Translational Neurodegeneration in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Translational Neurodegeneration indexed in Scopus?
Yes. Translational Neurodegeneration is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 25.9. Check its current status on the Scopus Sources page.
Is Translational Neurodegeneration in Web of Science?
Yes. Translational Neurodegeneration is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.
What is the impact factor of Translational Neurodegeneration?
The recorded journal impact factor of Translational Neurodegeneration is 19.1. Clarivate updates impact factors every year in Journal Citation Reports.
Is Translational Neurodegeneration open access, and what does it charge?
Translational Neurodegeneration is an open-access journal and its APC is USD 3,090. Fees change, so check the journal's website before you submit.
How long does Translational Neurodegeneration take to publish?
The recorded average time from submission to publication is about 10 weeks. Individual papers can take longer, especially when revisions are requested.
Who publishes Translational Neurodegeneration?
Translational Neurodegeneration is published by Springer Nature in United Kingdom, under ISSN 2047-9158.
Research profile
- 646articles indexed
- 41,657citations
- 99h-index
- 18.992-year mean citedness
- 1979first year indexed
Main research topics: Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Dementia and Cognitive Impairment Research, Neuroinflammation and Neurodegeneration Mechanisms, Deep Brain Stimulation and Movement Disorders, Amyotrophic Lateral Sclerosis Research.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Medicine journals (8,023)
- Neuroscience journals (681)
- Cellular and Molecular Neuroscience journals (102)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in DOAJ (10,243)
- Journals indexed in HEC (34,823)
- Scopus Q1 journals (9,924)
- Web of Science Q1 journals (4,519)
- HEC W-Category journals (13,616)
- Journals published in the United Kingdom (7,333)
- Springer Nature journals (2,655)